Medical Advanced Technology (AFRRI)
Abstract
For the Uniformed Services University of the Health Sciences/ Armed Forces Radiobiology Research Institute (USUHS/AFRRI), this program supports applied research for advanced development of biomedical strategies to prevent, treat and assess health consequences from exposure to ionizing radiation. It capitalizes on findings under PE 0602787HP, Medical Technology, and from industry and academia to advance novel medical countermeasures into and through pre-clinical studies toward newly licensed products. Program objectives focus on mitigating the health consequences from exposures to ionizing radiation(alone or in combination with other injuries) that represent the highest probable threat to US forces in current tactical, humanitarian and counterterrorism mission environments. Findings from basic and developmental research are integrated into focused advanced technology development studies to produce the following: (1) protective and therapeutic strategies; (2) novel biological markers and delivery platforms for rapid, field-based individual medical assessment; and (3) experimental data needed to build accurate models for predicting casualties from complex injuries involving radiation and other battlefield insults. The AFRRI, because of its multidisciplinary staff and exceptional laboratory and radiation facilities, is uniquely positioned to execute the program as prescribed by its mission.
Document Details
- Document Type
- R2 Budgetary Justification
- Publication Date
- Oct 01, 2022
- Source ID
- 0603002DHA_2_0130_PB_2022
- Change Summary Explanation
- Service Agency Name
- Defense Health Agency
Entities
Organizations
- Defense Health Agency
Related Documents
- Child Project: CSI - Congressional Special Interests
- Child Project: Biodosimetry (USUHS)
- Child Accomplishment: Biodosimetry (USUHS)
- Child Project: Radiation Countermeasures (USUHS)
- Child Accomplishment: Radiation Countermeasures (USUHS)